1224357

Jonathan M Spergel MD PhD — FEI 3015892395

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 1, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Philadelphia, PA (United States)

Additional Details

Clinical Investigator (CI)